Vijay Chudasama

Better Together

Antibody drug conjugates offer a great deal of potential for drug targeting, but what’s the best way of linking drugs and antibodies? Indeed, is there a single ‘best way’ in the context of the broad range of antibodies, drugs and diseases to which this modality is applicable?